To join our list of Partners for 2027, fill out our partnership brochure below.
Headline Partner
Zoetis
Website: www.zoetis.com
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees.
For more information, visit www.zoetis.com
Platinum Partners
Boehringer Ingelheim
Website: www.boehringer-ingelheim.com
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, Boehringer provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain.
Elanco
Website: www.elanco.com/en-us
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet.
MSD Animal Health
Website: www.msd-animal-health.com
At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of MSD. Through its commitment to The Science of Healthier Animals®, MSD Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com and connect with us on LinkedIn and X (formerly Twitter).
Associate Partners
Ceva
Website: www.ceva.com/en
It’s estimated that a staggering 75% of all emerging human infectious diseases originate from animals and birds. These zoonoses, as they’re known, are what compel Ceva to innovate – to succeed in the fight against the likes of avian flu, brucellosis and Q-fever. They’re one of the driving forces behind our vision: ‘Together, beyond animal health’.
Ceva works with welfare and social programmes around the world to bring this vision to life – anywhere our products and know-how can make a difference and with all kinds of partners. From Uganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
They’re truly global, based in 46 countries and working across more than 110. We have 12 R&D centres, 25 production sites and more than 5000 employees worldwide.
Dechra
Website: www.dechra.com
Dechra is a global leader in veterinary specialty care, dedicated to the sustainable improvement of animal health and welfare.
They develop, manufacture, market, and sell high-quality therapies for dogs, cats and horses with a focus on endocrinology, internal medicine, dermatology and pain management.
Operating in dozens of countries with multiple manufacturing sites and ~2,500 global employees, Dechra delivers both innovation and trusted support to veterinary healthcare teams and pet parents worldwide.
MWI Animal Health
Website: www.mwiah.com
To support the veterinary practice of the future, we’ve combined the expertise of Centaur Services, St Francis Group, Vetswest buying groups and Vet Space practice management technology to provide a flexible, comprehensive solution. From manufacturer relationships to patients’ visits, we’re working to address practices’ needs and improve animal health in the UK/ We’re turning data into insight and insight into action, giving our customers more time to provide even better care. We are united in our responsibility to create healthier futures.
Executive Consulting Partner
Stonehaven Cozmix Group
Website: www.sc.group
Stonehaven Cozmix Group (SC Group) is a global life sciences management consultancy firm that serves innovative life sciences companies at various phases of development. The company was created upon the merger of Stonehaven Consulting AG and Cozmix Inc.
Cozmix was founded in 2005 and has successfully advised life science clients in commercial resource allocation with their proprietary tools and software suite. Stonehaven Consulting was established in 2015 and has since then delivered numerous strategy projects for clients in animal health, human health, and private equity.
The merger creates an international leader in life science consulting, focused on commercial strategy and commercial resource allocation where clients can benefit from a broadened service and technology offering, addition expertise, and expanded global presence with offices in Switzerland, UK and USA.
Knowledge Partner
McKinsey & Company
Website: www.mckinsey.com
McKinsey is a global management consulting firm committed to helping organizations accelerate sustainable and inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.
Start-Up Development Partner
Paul Dick and Associates
Website: pauldickassociates.com
Pda is a global consulting company with extensive expertise and experience in the animal health and veterinary sectors. We assist companies in terms of creating corporate value, mitigating their product development risks and, with this, accelerating their technologies into the commercial market place. These products/services include supplements, medical devices, diagnostics, digital technologies, telehealth, big data and AI, and innovations in veterinary medicine.
Our services include developing tailored strategies including conducting detailed market assessments, developing go-to-market and regulatory strategies, securing regulatory approvals, facilitating connections with strategic corporate partners and investors at the right stage. We also provide various levels of mentorship to companies as they further develop and commercialize their products/services. Further, we also create and manage expert Advisor Committees, and participate on Boards.
As Kisaco’s Start-Up Development Partner across all events, we are keen to explore synergies and potential areas of partnership.
Business Focus: deal management, growth consultant, regulatory, supplements, telehealth, therapeutics, vet med, wearables
Senior Event Partners
AskVet
Website: askvet.app
AskVet is the leading AI and data-driven technology company in animal health. We use AI and our proprietary companion animal and livestock data to build highly intelligent veterinary agents that will join the workforce – enhancing engagement, improving efficiency, and supporting revenue growth for animal health organizations.
In 2023, AskVet introduced VERA (Veterinary Engagement & Relationship Agent), the world’s only AI veterinarian. VERA is trained on over 2.5 million recorded conversations between veterinarians and animal owners, curricula from six veterinary colleges, and more than 180 curated medical, nutritional, and behavioral data sets. She currently converses in 50 languages.
As a customizable conversational AI, VERA powers medical triage, operational support, customer acquisition, sales, retention, and back-end automation – making her an invaluable asset across the animal health ecosystem.
Demand in the US for animal health care for both companion animals and food production animals is outpacing supply of qualified veterinarians and technicians. The US animal health industry needs to use data and AI to augment and expand the available supply of human veterinary expertise to close the supply and demand gap. And the problem is much worse if you look at the global growth of companion and food production animals. AskVet has created a suite of data/AI products on the VERA platform where companion and food animal businesses can use their propriety data and VERA’s veterinary expertise to create differentiation and competitive advantage.
Bioceltix
Website: bioceltix.com/en
Bioceltix is a Poland-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action of MSC, will be an alternative to the symptomatic pharmacotherapy focused mainly on alleviating pain and inflammation. Our goal is to create analgesic and anti-inflammatory biopharmaceuticals that will induce the natural mechanisms of regenerating tissues affected by the disease. In our pipeline we have products intended for the treatment of atopic dermatitis and osteoarthritis in dogs and of arthritis in horses – all in the advanced development stage. Bioceltix expects the first drug registration for osteoarthritis in dogs in 2025 as the registration procedure in the European Medicines Agency has been launched. We are led by the motto: More than animals, more than technology.
BiomEdit
Website: www.biomedit.com
BiomEdit is a microbiome innovation company that discovers, designs and develops novel probiotics, microbiome derived bioactives and engineered microbial medicines to address unmet needs in animal health. We partner with Ginkgo Bioworks to amplify and accelerate product discovery and development with a goal of introducing breakthrough innovation for livestock producers and veterinarians.
Circa Healthcare
Website: www.circahealthcare.com
We’re an Animal-health and Petcare focused, strategic marketing and communications agency. We know there’s no such thing as a ‘normal’ communications challenge. That’s why we unite a unique blend of strategy, collaboration, creativity, and understanding of the Petcare and Animal Healthcare worlds—and everything in them—that you won’t find anywhere else to produce abnormally brilliant results for our clients. It’s not normal. But that’s what we’re all about.
Clinglobal
Website: www.clinglobal.com
Clinglobal is a global, science-based, quality-driven group dedicated to accelerating innovation by providing services and solutions to the animal care industry through the ever-expanding Clinglobal group of companies. Animals are our passion, and people are our strength. Together, we better lives by accelerating animal health innovation.
Our unique business model allows the animal health industry and community to benefit from simplified, comprehensive, and customisable contracting solutions for animal health and nutrition product development and registration.
Our group include companies such as Clinvet (preclinical and lab clinical studies in companion and production animals), Clindata (data management and statistical analysis solutions), Clinomics (molecular biology, clinical pathology and immunology R&D laboratory), rtilab (microbiology and clinical pathology R&D laboratory) and Clinglobal (product development consultancy, regulatory affairs and quality assurance services), as well as an extensive network of strategic partners across geographies and fields of expertise.
Eirgen
Website: www.eirgen.com
Eirgen Pharma is a specialist Contract Development and Manufacturing Organization (CDMO) based in Ireland, supporting global partners in both human and animal health. With deep veterinary formulation expertise, Eirgen develops species-specific oral solid dose medicines designed to improve compliance and treatment outcomes for companion animals.
From palatability enhancement and taste masking to chewable delivery formats, Eirgen ensures medicines are easier to administer, safe, and effective across dogs, cats, and other companion animals. Their fully integrated model spans product development, regulatory guidance, clinical supply, and commercial-scale manufacturing, with in-house packaging and a 750 million unit annual capacity.
Eirgen’s lean and agile approach enables accelerated technology transfer and rapid time-to-market, routinely completing transfers in under four months. Partners benefit from fast proposal turnaround times, collaborative pricing, bi-weekly project visibility, and dedicated technical support.
Acquired by OPKO Health in 2015, Eirgen delivers a seamless end-to-end pathway from concept to market, ensuring high-quality veterinary medicines reach animals, their owners, and our partners quickly, reliably, and cost-effectively.
Enzene
Website: www.enzene.com
Enzene is an end-to-end CDMO with services spanning discovery, development, and commercial supply, operating integrated sites in Pune (India) and New Jersey (USA). As a pioneer in next-generation biologics technologies, Enzene is disrupting the existing biologics manufacturing paradigm with its patented EnzeneX™ technology—the first fully-connected continuous manufacturing (FCCM) platform validated for commercial biologics supply. We partner with innovators and biosimilar developers to deliver accelerated time-to-market, increased production yields, and cost reductions across a broad range of biologic modalities. Committed to pushing the boundaries of biologics manufacturing innovation, Enzene is striving to reduce monoclonal antibody production costs to below $40 per gram by 2025.
For more information on Enzene, a subsidiary of Alkem Laboratories Ltd, please visit www.enzene.com
knoell
Website: www.knoell.com/en/markets/animal-health
knoell is the only knowledge-based animal health consultancy and clinical studies specialist with its own technical staff based on three continents: North America, Europe, and Asia. This means easy access and broad reach for you as our valued client into the animal health market. It also benefits you by avoiding duplication, providing a better return on investment for valuable data, improving control of expenditure, and reducing administration.
With the arrival of the two well-known and established brands Cyton and Triveritas in the knoell group, knoell was able to expand their business into the animal health market. Both companies have more than two decades of experience in the animal health market in Europe and the USA. The joint activities led to growth of the animal health business in Europe, the US and Asia as well. In order to strengthen its presence in the USA, knoell Animal Health LLC was founded in early 2020. Since February 2021, Triveritas operates as knoell Animal Health Ltd.
With animal health experts working in the US, Europe and Asia and an established network of trusted partners, knoell can support clients' business aspirations better than ever before and provide a truly global service.
Our animal health team offers a full portfolio of services, including start-to-finish product development and ad hoc services.
Pet Flavors
Website: www.petflavors.com
PF, Inc. (Pet Flavors, Inc.) is the world leading developer and manufacturer of quality flavor bases for both pharmaceutical drugs and nutritional supplements in the animal health industry. PF Inc. sells several types of flavor bases for use in formulating palatable canine, feline, and equine dosage forms that are sold on a worldwide basis. PF’s Artificial Powdered Beef Flavor; PC-0125 is sold to 9 of the top 10 largest animal health pharmaceutical companies in the world and has been successfully formulated in over 20 New Animal Drug Approvals (NADAs). Our company has over 30 years of experience with formulation and product development. With an active ingredient and our flavor bases we can create highly palatable chewable tablets, soft chews or granules. Our services include improving the palatability of an existing product, creating product line extensions or developing entirely new products. Please visit our website www.petflavors.com for detailed information.
Phibro Animal Health Corporation
Website: www.pahc.com
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We sell approximately 780 product lines in over 80 countries to approximately 3,790 customers. We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through animal feed manufacturers, wholesalers, distributors and veterinarians.
We are investing resources to develop future products for the companion animal sector. Our business is currently concentrated in the livestock sector.
Sidley Austin
Website: www.sidley.com/en/eu
Sidley’s Global Life Sciences practice takes an integrated, multidisciplinary approach to serving animal health clients worldwide, addressing their full spectrum of legal needs with the goal of enhancing animal health and wellbeing, as well as securing high-quality sources of protein. We draw on our deep industry expertise and understanding of regulators to develop sophisticated strategies for engaging with key authorities, such as the FDA, European Medicines Agency (EMA), European Commission, the UK Veterinary Medicines Directorate (VMD), and China’s National Medical Products Administration (NMPA). We also maintain strong relationships with leading industry bodies, including HealthforAnimals, AnimalHealthEurope, and the National Office of Animal Health (NOAH).
Our highly credible animal health practice is led by Dr. Chris Boyle, a qualified veterinary surgeon and recognised thought leader in the sector, enabling Sidley to support clients in areas such as: promotion of veterinary medicines, commercialisation including discounts and rebate schemes, antitrust/competition law, product recalls, suspension of marketing authorisations by regulators, cross-border and online retail of veterinary medicines, off-label use and compounding, supplementary protection certificates, and regulatory classification of products including borderline issues (e.g. between veterinary medicines, supplements, feeds, medical devices, and pesticides). Our comprehensive practice includes transactional expertise led by Robert Darwin, a prominent M&A, Private Equity, and life sciences lawyer. Robert advises global life sciences corporations and investors on a range of deals, including acquisitions, strategic collaborations, and private equity buyouts. His close collaboration with our regulatory team streamlines due diligence and addresses key regulatory issues for prospective buyers.
Sidley’s Animal Health Legal Forum (AHLF), hosted by our Global Animal Health Practice and Dr Chris Boyle, is a unique network that connects in-house animal health lawyers, regulatory affairs and compliance professionals, and investors. It serves as a platform for discussing the latest industry developments, sharing best practices, and fostering connections within the animal health community.
Syngene International Ltd.
Website: www.syngeneintl.com
Syngene is a leading integrated research, development, and manufacturing partner serving the pharmaceutical, biotechnology, and animal health industries. With world-class infrastructure and compliance with global regulatory standards, we collaborate with animal health innovators to deliver breakthrough solutions that improve the well-being of livestock and companion animals.
Our comprehensive capabilities span small molecules, biologics, and specialty products across the drug lifecycle, from concept to clinic. Syngene’s team of more than 6,000 scientists combines deep expertise with the capacity to deliver exceptional science, robust data security, and world-class manufacturing at speed, helping accelerate time-to-market and reduce the cost of innovation.
Trusted by industry leaders worldwide, Syngene combines scientific excellence with operational agility to accelerate innovation and bring safe, effective products to market faster.
United Animal Health
Website: www.unitedanh.com
United Animal Health, founded in 1956, is a research-driven company that helps protein producers raise healthier animals to feed a growing world. United Animal Health offers livestock nutrition and health products globally through the United Animal Health or affiliate brands. To learn more, visit UnitedAnH.com.
Vido
Website: www.vido.org
The Vaccine and Infectious Disease Organization (VIDO) is one of the world’s largest and most advanced containment facilities and is internationally recognized for its role in infectious disease research and vaccine development. Based at the University of Saskatchewan, VIDO has conducted infectious disease research and vaccine development for almost half a century – commercializing eight vaccines with six being described as ‘world-firsts’. During the COVID-19 pandemic, VIDO tested more than 500 medicines for organizations worldwide. The organization’s 200+ personnel operate using an ISO9001 certified management system. Current infrastructure includes BSL2, BSL3, BSL3-Ag containment with an integrated BSL3 capable GMP vaccine manufacturing facility. As part of its expansion to enhance pandemic preparedness, VIDO is adding BSL4 capacity and a new BSL2 animal housing facility. This facility will be able to handle a wide range of species, from small disease vectors to bison. VIDO is also an active participant in several international networks, including the CEPI Animal Model Network, INTERCEPTOR, RAV3N, and NATO DIANA, and holds multiple NIH contracts for preclinical animal models and biomanufacturing.
WuXi Biologics
Website: www.wuxibiologics.com
WuXi Biologics is a leading contract research, development and manufacturing organization (CRDMO) that provides end-to-end capabilities to healthcare organizations worldwide. With operations in China, the United States, Ireland, Germany, and Singapore, we enable our partners to effectively and efficiently bring biologics and vaccines to patients worldwide through our comprehensive and high-quality drug development model.
Event Partners
AB7 Sante
Website: www.ab7group.com/en/home
AB7 Santé is a French Veterinary Pharmaceutical Laboratory that has been innovating for over 50 years in the field of Animal Health.
Fully integrated for greater agility, AB7 specializes in research, development, production, quality control, registration, and sales of veterinary medicines, generics, OTC products, biocides, and pet care solutions for the global market. With its industrial expertise and two certified facilities in France (GMP) and the United States (EPA), AB7 is well-equipped to handle specific manufacturing needs, from small batches to large-scale production, while ensuring high-quality standards. Our flexibility allows us to adapt manufacturing resources, methods, and technologies as required.
As a CDMO company, we provide pharmaceutical and non-pharmaceutical outsourcing services, from development to manufacturing, with an innovative, sustainable, and responsible approach.
AB7 continuously invests in R&D and manufacturing expertise, maintaining state-of-the-art equipment that meets EU GMP standards. With five R&D laboratories specializing in Liquid and Solid Formulation, Analytical Development, Microbiology, and Entomology, we partner with both small and large pharmaceutical companies to create innovative, high-quality products that meet their specific needs.
Specialized in exclusive drug delivery systems, AB7 supports its partners in developing innovative products, while also providing a full range of traditional formulations.
At AB7, our goal is to address today’s animal health and welfare challenges by working with international partners to achieve this mission together.
ALS
Ashish Life Science (ALS) is a global veterinary pharmaceutical company delivering reliable animal health solutions and dependable supply. Headquartered in India, we export to over 60 countries across Europe, Australasia, LATAM, Africa and the Middle East. We hold European GMP, Australian GMP and several other GMP approvals worldwide.
ALS has a strong in-house product portfolio and an active pipeline under development. We manufacture tablets, bolus, liquids, pastes, powders, injectables, soft chews and spot-on products. We also provide CMO and CDMO services across development, dossiers, scale up, packaging and supply. Through ALS Holland BV, we perform batch testing and batch release in Europe to support smooth and compliant market entry. Our focus is delivering quality, partnership and long-term value
Argenta
Website: www.argentaglobal.com
About Argenta
Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and wellbeing of pets and farm animals. Founded in 2006, we are the only combined global contract research, development, and manufacturing organisation (CRO/CDMO) specialising in animal health and nutrition. From ‘molecule to market’, our innovative solutions cover every stage of product development, spanning pharmaceutical development, novel drug delivery technologies, (pre-)clinical and regulatory services, and manufacturing. We’re trusted by the majority of the world’s top 10 animal health companies, and customers return to Argenta for our unparalleled, comprehensive support. With bases in Europe, New Zealand, and the USA, our 650+ colleagues are driven by our partnership approach and purpose: Healthy Animals. Let’s Make It Happen, Together. For more information, please visit www.argentaglobal.com.
Axiota Animal Health
Website: axiota.com
Axiota® Animal Health is an innovation-driven company that discovers, develops, and markets products for beef and dairy producers around the world. Axiota’s focus is to deliver superior, first-in-class products that are scientifically proven with known modes of action, provide measurable commercial efficacy and are accepted by consumers. Axiota’s non-antibiotic solutions prepare cattle to thrive during transition and stress and support producers’ goals of optimal health, performance, and animal well-being.
Channelle Pharma
Website: chanellepharma.com
Chanelle Pharma is a global pharmaceutical leader in human and animal health. As an end-to-end, fully integrated partner, the company serves B2B, consumers, and wholesale markets, combining development, manufacturing, and commercialisation under one roof. Chanelle delivers reliable services across the full product value chain, provides immediate access to a broad product portfolio, and drives growth through strategic partnerships.
With operations in Ireland, the UK, Portugal, and Jordan, the company supplies high-quality, reliable, and affordable products to more than 90 countries, underpinned by a commitment to innovation, sustainability, and differentiated customer value.
Covetrus
Website: softwareservices.covetrus.com/emea
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. A company passionate about advancing the world of veterinary medicine with big goals when it comes to delivering the best in animal care. As a newly formed and global company, they bring together products, services, and technology into a single platform, connecting their customers to the solutions and insights they need to work best.
Dômes Pharma
Website: www.domespharma.com
Founded 79 years ago, Dômes Pharma is a 100% family-owned French animal health group, dedicated to companion animals.
With sales of 95m€ and 400 employees, the Group develops and markets over 140 products (including 65 medicines) in more than 30 countries on two continents, through its six subsidiaries and 30 distributors.
The Group's mission is simple: to (re)invent, with passion and humanity, solutions for the health and well-being of pets, for greater complicity and a better life.
This is reflected in a clear strategy: to provide dog and cat owners and caregivers with innovative products and services that are useful to their practice and business, in cutting-edge therapeutic areas such as ophthalmology, epilepsy, poisoning management, anxiety and digestive.
CSR consideration is central to the relationship between DÔMES PHARMA and its partners.
Gyrus Capital
Website: www.gyruscapital.com
Gyrus Capital is a European investment firm with €1.5 billion under management dedicated to transformational investments in the Healthcare (Human, Animal and Environmental) and Services sectors. Based in Geneva, Switzerland, Gyrus specialises in Founder/Family businesses and in Corporate Carve-outs with a proven ability to navigate complexity, and operates with a partnership approach bringing in-depth knowledge and expertise enabling founders and managers to unlock transformational value. Gyrus typically invests into mature companies with entry investments upwards of €30 million.
Invenesis
Website: invenesis.com
Invenesis is a Swiss-based Contract Research Organization (CRO) specializing in early discovery and translational biology for animal health and One Health applications. We support pharmaceutical and biotech partners with integrated expertise in parasitology, electrophysiology, molecular biology, and high-throughput phenotypic screening, accelerating the identification and validation of novel antiparasitic and neuroactive compounds.
Invetus
Website: www.invetus.com
Invetus is a leading Australian veterinary Contract Research Organisation (CRO) dedicated to advancing global animal health through independent, high-quality scientific research. With decades of collective experience, Invetus provides trusted technical expertise and continuity across the veterinary pharmaceutical development lifecycle.
We partner with more than 200 animal health companies worldwide, supporting innovation across companion and production animal sectors. Our capabilities include GCP- and GLP-compliant efficacy trials, pharmacokinetic and bioequivalence studies, target animal safety and tissue residue investigations, complemented by specialist research programs in veterinary oncology, pain management models, and nutritional palatability and digestibility.
Invetus operates in state-of-the-art research facilities and an extensive clinical network across Australia, offering access to diverse species, environments, and off-season study opportunities for field studies in animals with naturally occurring conditions. All programs are underpinned by rigorous Quality Assurance oversight, delivering robust, regulator-ready data trusted by global sponsors.
At AHNTI-EU, we look forward to engaging with veterinary pharmaceutical leaders to explore collaborations that accelerate safe, effective animal health solutions.
KCI Biotech
Website: www.kcibiotech.com/en
KCI Biotech and its wholly-owned subsidiary, KMQ Biotech and KAL Biotech are CROs specializing in providing preclinical pharmacodynamics and durability evaluation services for pharmaceutical research and development. The company owns AAALAC-accredited state-of-the-art laboratory animal facilities in Suzhou and Nantong,with a total area of more than 40,000m²,which can meet the needs of various types of preclinical research. The company has a full range of laboratory animal platforms including rats, mice, hamsters, guinea pigs, rabbits, cats, ferrets, dogs, pigs, sheeps and non-human primates. The in vivo pharmacolofical department supplies more than 400 animal disease models for human medicine development research. The BSL2/ABSL2 department supplies more than 100 pathogenic microorganisms, including bacteria, viruses, and fungi for human medicine development research, veterinary medicine and pet medicine. The company also supplies pathology, toxicology, pharmacokinetics, cellular and molecular biology, and medical imaging services. The company has already cooperated with more than 1,000 famous domestic and international pharmaceutical companies , and completed more than 2000 domestic and international projects . With a professional R&D team, rich experience in in vivo pharmacology and pharmacodynamics evaluation, and a professional spirit of integrity and excellence, KCI/KMQ/KAL will provide a full range of preclinical drug discovery and development services for global pharmaceutical companies and research institutions, and establish a professional and efficient drug discovery and evaluation system.
Lawless Strategic Communications
Website: www.lawlesscomms.com
At Lawless Strategic Communications, we're your Corporate Communications experts. With decades of success leading Corporate Communications at top-tier public and private companies, Julie Lawless launched Lawless Strategic Communications in 2022, bringing the Purpose + Passion approach to serve companies in animal health and nutrition, veterinary and food production sectors. From the most complex reputational and brand issues to routine transaction communications, thought leadership, internal engagement and ESG programs, our knowledge and expertise can produce significant results. We understand the industry and quickly work alongside you to enhance and protect your vision - always grounded in your strategy and Purpose. Visit us today to learn more about our approach and how we can help you at www.lawlesscomms.com.
Markel
Website: uk.markel.com
A leading global specialty insurer with a truly people-first approach.
We create the best solutions possible, regardless of where in the world you or your clients are. We share our insights and knowledge, and our experts spend time with companies to help them understand complex and ever-shifting environments.
We created the Global Livestock (Re)Insurance Consortium, an insurance arrangement that means clients benefit from the simplicity of one insurer with the financial strength of seven.
Our team of expert underwriters work closely with a wide range of clients, from individual farms to international livestock operations, to develop market-leading animal mortality insurance solutions.
Medfiles
Website: medfilesgroup.com
Medfiles has been supporting its clients on the path of commercialisation in Animal Health for over 15 years. We provide flexible solutions for our clients’ outsourcing needs in areas of R&D and analytical, Regulatory Affairs, Pharmacovigilance and Feed Regulatory.
The Veterinary Medicines Teams of our Regulatory Affairs and Pharmacovigilance units can help you navigate the registration and maintenance processes of medicines smoothly and support our client in post-authorisation activities at both local and global level.
Whilst our Feed Regulatory services can support Feed business operators from product development to launch in Feed Materials and Feed Additives.
If you lack in-house veterinary expertise or resources, Medfiles’ experts are happy to help with projects, both large and small.
OFD Life Sciences
Website: www.ofdlifesciences.com
OFD Life Sciences leverages over 60 years of freeze-drying expertise to provide specialized lyophilization services for the animal health and pharma industries. We focus on preserving the potency and shelf-life of sensitive ingredients to deliver vaccines, biologics, probiotics, and specialty APIs.
A key differentiator for our animal health partners is our LyoPastille® technology. This patent-pending format creates fast-dissolve, precisely dosed tablets that significantly improves compliance and ease of administration and may even be leveraged to create orally dosed vaccines, eliminating the need for needles.
As a leading lyophilization-focused CDMO, OFD Life Sciences offers comprehensive support from R&D and formulation to large-scale commercial production. By combining deep engineering heritage with advanced formulation science, we help animal health companies overcome stability challenges, reduce cold-chain dependency, and deliver high-quality, effective treatments to the global veterinary market.
Vbiosci
Website: www.vbiosci.com/en
Vbiosci is a Beijing-based biotechnology leader dedicated to revolutionizing animal health through embryo-free and serum-free vaccine development. Our proprietary full-suspension cell culture technology sets a new global standard—delivering higher productivity, lower costs, and reduced contamination risks compared to conventional egg-based or anchorage dependent cell culture methods.
Cutting Edge Process Technologies
- Avian Vaccines
- Serum-free, full-suspension manufacturing in large-scale bioreactors maximizes efficiency while eliminating supply chain and safety limitations of embryonated eggs. Examples include Newcastle Disease (NDV), Infectious Bronchitis (IBV), and Fowl Adenovirus (FAdV) vaccines.
- Livestock Vaccines
- Advanced serum-free suspension cell culture platform slashes production costs and contamination risks for broader animal health applications compared to serum dependent and anchorage-dependent processes. Examples include Pseudo Rabies Virus (PRV), Porcine Circovirus 2 (PCV2), Bovine viral diarrhoea virus (BVDV) vaccines.
Vet AI
Website: www.vet-ai.com
Founded in 2017 by veterinary and technology specialists, Vet-AI is on a mission to make pet care more accessible and affordable. Our unique “vet + tech” approach is driving solutions across clinical trials, telemedicine and diagnostics. The outcome is faster, smarter and safer care for pets everywhere, while supporting veterinary professionals and stakeholders in navigating the demands of a rapidly evolving industry.
Vet-AI’s journey began with telemedicine, now serving 1.5 million UK pet owners, a 96%+ customer satisfaction rating and cost savings worth millions for partners. This success paved the way for innovations including automated triage, AI-powered health checks and a state-of-the-art trial management system addressing key gaps in end-to-end trials. Built on 4 billion data points and outperforming global AI systems, these solutions leverage high-quality data. They are validated by world-renowned scientists and technologists, alongside experienced veterinarians who review and assess outputs.
Each unique offering now gives global pet health companies, insurers, food brands and research organisations a competitive edge, streamlining operations to save time and money, while maintaining the highest standards.
Vetoquinol
Website: www.vetoquinol.com/en
Founded in 1933, Vetoquinol is the 9th largest veterinary pharmaceutical business, committed to the protection and well-being of both animals and people.
Vetio Animal Health
Website: vetio.com
As a Contract Development and Manufacturing Organization (CDMO) dedicated to Animal Health, Vetio integrates product development, analytical services, technical services, and commercial manufacturing of veterinary pharmaceuticals using a Quality-by-Design approach. Vetio is your single-source partner for successful product approval, scale-up, and ongoing commercial supply.
Vetio has provided expertise to animal health companies around the world since 2001 and is committed to the development and manufacturing of products that improve the lives of animals, while assuring the safety, quality and compliance of our products to the highest industry standards.
Ask Us about our intellectual property in pharmaceutical soft chews and palatability. Please visit www.vetio.com and watch our brief company overview video.
Media Partners
All About Feed
Website: www.allaboutfeed.net
All About Feed is a true multimedia brand, bringing you the latest developments in animal nutrition, diet formulation, and feed processing equipment. We deliver the best articles right in your inbox - subscribe for our e-mail newsletter by clicking here.
British Veterinary Association (BVA)
Website: www.bva.co.uk
BVA champions, supports, and empowers more than 18,000 vets across the UK, making sure that their work is valued, their careers are rewarding, and their expertise is influential. Why? Because vets play an essential role in society and investing in them directly affects the health and welfare of the animals they care for. Protecting the wellbeing of our animal population is good for the animals, good for the planet, and good for the people who live on it.
European Healthcare Investor Association
Website: www.ehia.org
Please visit our website for more information.Feed and Additive
Website: www.feedandadditive.com
Creating an active and strong interaction through its online issue, website, e-newsletter, and social media channels, Feed & Additive Magazine aims to build a bridge between industry representatives who conduct research and develop new products as well as ideas for a sustainable animal production system. Subscribe to our magazine and never miss an update! Click the link here to join our community and stay informed with the latest industry insights.
https://www.feedandadditive.com/subscribe/
Feline Business Brief
Website: www.felinebizbrief.com
Please visit our website for more information.Fish Farmer
Website: www.fishfarmermagazine.com
Fish Farmer is a monthly publication that has been serving the aquaculture industry as a Leading source of news, analysis and comment for more than 40 years. Based in the UK, the magazine has a worldwide distribution and also brings up to date news to its readers via its dedicated website www.fishfarmermagazine.com.
International Animal Health Journal (IAHJ)
Website: international-animalhealth.com
International Animal Health Journal (IAHJ) looks into the entire outsourcing management of the Animal Health Industry. We aim to create a communication platform, which will educate producers on the best practice guidelines and the latest technological advancement surrounding animal medicines, animals in the food chain, animal physiology, animal diseases and treatment options. It is a comprehensive guidebook packed with both practical and scholarly information. Medical, veterinary, technical and professional knowledge, accurate, clear and objective, crucial to keeping animal’s healthy and animal-derived food safe. The journal is dedicated to pharmaceutical professionals, medical device manufacturers and animal feed producers as well as public health officials.
Pet Business World
Website: www.petbusinessworld.co.uk
Pet Business World is the UK’s leading news magazine and website for the pet and aquatics industry. We distribute 7,711 copies (November 2018) to qualifying pet trade professionals – the biggest circulation in the specialist trade by a considerable margin. The independently-owned magazine was established in 1951 and the website (www.petbusinessworld.co.uk) attracted more than 37 million hits in the 12 months to October 2018 – and rising!